Current reports
8-K
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
4 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
19 Mar 24
8-K
Unregistered Sales of Equity Securities
18 Mar 24
8-K
Unregistered Sales of Equity Securities
12 Mar 24
8-K
Departure of Directors or Certain Officers
6 Mar 24
8-K
TCBP Provides Shareholder Update and Highlights Upcoming Milestones
14 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Jan 24
6-K
TC BioPharm Announces Pricing of $3.5 Million Public Offering
21 Dec 23
6-K
TC BioPharm Announces Plan to Implement ADS Ratio Change
13 Dec 23
6-K
Current report (foreign)
2 Nov 23
Registration and prospectus
424B4
Prospectus supplement with pricing info
20 Dec 23
F-1/A
Registration statement (foreign) (amended)
14 Dec 23
F-1/A
Registration statement (foreign) (amended)
12 Dec 23
424B3
Prospectus supplement
8 Nov 23
F-3/A
Shelf registration (foreign) (amended)
2 Nov 23
F-3
Shelf registration (foreign)
29 Sep 23
424B3
Prospectus supplement
1 Sep 23
424B3
Prospectus supplement
1 Sep 23
F-1
Registration statement (foreign)
28 Aug 23
424B3
Prospectus supplement
11 Apr 23
Other
EFFECT
Notice of effectiveness
19 Dec 23
CORRESP
Correspondence with SEC
14 Dec 23
EFFECT
Notice of effectiveness
7 Nov 23
CORRESP
Correspondence with SEC
2 Nov 23
UPLOAD
Letter from SEC
4 Oct 23
UPLOAD
Letter from SEC
30 Aug 23
EFFECT
Notice of effectiveness
28 Mar 23
CORRESP
Correspondence with SEC
23 Mar 23
UPLOAD
Letter from SEC
16 Feb 23
EFFECT
Notice of effectiveness
27 Dec 22
Ownership
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
MEDINET Co., Ltd.
29 Jan 24
SC 13G
Nipro Corp
28 Feb 23
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 23
SC 13G
MEDINET Co., Ltd.
30 Jan 23
4
Diana Elizabeth Randall
11 Jan 23
4/A
Mark Edward Randall
11 Jan 23
4/A
Kenneth Edward Randall
11 Jan 23
4
Mark Edward Randall
11 Jan 23
4
Kenneth Edward Randall
11 Jan 23